Award Overview
Gilead Sciences Poland Sp. z o.o. was awarded Poland – Antineoplastic agents – 126/PN/2024 - dostawa produktu leczniczego Axicabtagene ciloleucel dla UCK by Uniwersyteckie Centrum Kliniczne in Poland, tracked by GlobalGov. The award is valued at $4.7M. It was awarded on November 5, 2024. Full award details and the issuing agency are below.
See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.
Start FreeAward Details
| Awardee | Gilead Sciences Poland Sp. z o.o. |
|---|---|
| Awardee country | Poland |
| Awarding agency | Uniwersyteckie Centrum Kliniczne |
| Country | Poland |
| Award value | $4.7M |
| Award date | November 5, 2024 |
| Last verified | September 2, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Track every Poland contract award and the opportunities behind them. Free for 14 days.
Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required